Frontiers in Pharmacology (Dec 2021)
Corrigendum: C1q/TNF-Related Protein 9 Attenuates Atherosclerosis by Inhibiting Hyperglycemia-Induced Endothelial Cell Senescence Through the AMPKα/KLF4 Signaling Pathway
- Gang Wang,
- Gang Wang,
- Baihe Han,
- Baihe Han,
- Ruoxi Zhang,
- Qi Liu,
- Qi Liu,
- Xuedong Wang,
- Xuedong Wang,
- Xingtao Huang,
- Xingtao Huang,
- Dandan Liu,
- Dandan Liu,
- Weishen Qiao,
- Weishen Qiao,
- Mengyue Yang,
- Mengyue Yang,
- Xing Luo,
- Xing Luo,
- Jingbo Hou,
- Jingbo Hou,
- Bo Yu,
- Bo Yu
Affiliations
- Gang Wang
- The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
- Gang Wang
- Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
- Baihe Han
- The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
- Baihe Han
- Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
- Ruoxi Zhang
- Department of Cardiology, Harbin Yinghua Hospital, Harbin, China
- Qi Liu
- The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
- Qi Liu
- Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
- Xuedong Wang
- The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
- Xuedong Wang
- Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
- Xingtao Huang
- The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
- Xingtao Huang
- Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
- Dandan Liu
- The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
- Dandan Liu
- Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
- Weishen Qiao
- The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
- Weishen Qiao
- Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
- Mengyue Yang
- The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
- Mengyue Yang
- Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
- Xing Luo
- The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
- Xing Luo
- Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
- Jingbo Hou
- The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
- Jingbo Hou
- Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
- Bo Yu
- The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
- Bo Yu
- Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
- DOI
- https://doi.org/10.3389/fphar.2021.812384
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords
